financetom
Business
financetom
/
Business
/
EverCommerce Q4 Loss Widens, Revenue Rises; Q1, 2024 Revenue Outlook Set; Shares Drop After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EverCommerce Q4 Loss Widens, Revenue Rises; Q1, 2024 Revenue Outlook Set; Shares Drop After Hours
Mar 14, 2024 2:05 PM

04:28 PM EDT, 03/14/2024 (MT Newswires) -- EverCommerce ( EVCM ) reported a Q4 loss late Thursday of $0.12 per diluted share, widening from the loss of $0.09 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.02.

Revenue in the quarter ended Dec. 31 rose to $169.4 million from $161.8 million a year earlier.

Analysts surveyed by Capital IQ expected $172.4 million.

The company expects Q1 revenue of $160.5 million to $163.5 million. Analysts polled by Capital IQ expect $173.6 million.

The company projects 2024 revenue of $676 million to $696 million. Analysts surveyed by Capital IQ expect $731.9 million.

Shares of EverCommerce ( EVCM ) fell 3.2% in after-hours activity.

Price: 9.05, Change: -0.3, Percent Change: -3.21

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
HBT Financial, Inc. and CNB Bank Shares, Inc. Jointly Announce Strategic Transaction
HBT Financial, Inc. and CNB Bank Shares, Inc. Jointly Announce Strategic Transaction
Oct 20, 2025
BLOOMINGTON, Ill. and CARLINVILLE, Ill., Oct. 20, 2025 (GLOBE NEWSWIRE) -- HBT Financial, Inc. ( HBT ) , the holding company for Heartland Bank and Trust Company (“Heartland Bank”), and CNB Bank Shares, Inc. (OTC: CNBN) (“CNBN”), the holding company for CNB Bank & Trust, N.A. (“CNB Bank”), today jointly announced the signing of a definitive agreement pursuant to which...
US FDA approves Glaukos' new eye therapy
US FDA approves Glaukos' new eye therapy
Oct 20, 2025
Oct 20 (Reuters) - The U.S. Food and Drug Administration has approved a new eye therapy from Glaukos Corp ( GKOS ), giving patients a less painful and more convenient option to treat a progressive condition that can severely affect vision, the company said on Monday. ...
UK Competition and Markets Authority to Refer Proposed Merger of Shutterstock and Getty Images for Phase 2 Review
UK Competition and Markets Authority to Refer Proposed Merger of Shutterstock and Getty Images for Phase 2 Review
Oct 20, 2025
NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Shutterstock, Inc. ( SSTK ) today received notice from the UK's Competition and Markets Authority (CMA) of their intent to refer the proposed merger of Shutterstock ( SSTK ) and Getty Images Holdings, Inc. to a Phase 2 review process unless acceptable undertakings to address their competition concerns are offered. Shutterstock ( SSTK...
FTAI Infrastructure Says Unit's Repauno Port and Rail Terminal Got Approval to Build Underground Cavern System
FTAI Infrastructure Says Unit's Repauno Port and Rail Terminal Got Approval to Build Underground Cavern System
Oct 20, 2025
07:04 AM EDT, 10/20/2025 (MT Newswires) -- FTAI Infrastructure ( FIP ) said Monday that its Delaware River Partners unit's Repauno Port and Rail Terminal obtained approval to construct an underground cavern system from the New Jersey Department of Environmental Protection. The approval enables the construction of two underground granite caverns for the storage of liquefied petroleum gas products, with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved